Interventional Cardiology Review最新文献_第6页

Clinical and Radiographic Predictors of Successful Coronary Angiography Through Right Radial Artery Access. 通过右桡动脉通道成功进行冠状动脉造影的临床和影像学预测因素。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2023.04

Sohil Elfar, Ahmed Onsy, Mohamed Amr Farouk

{"title":"Clinical and Radiographic Predictors of Successful Coronary Angiography Through Right Radial Artery Access.","authors":"Sohil Elfar, Ahmed Onsy, Mohamed Amr Farouk","doi":"10.15420/icr.2023.04","DOIUrl":"https://doi.org/10.15420/icr.2023.04","url":null,"abstract":"Background: One of the limitations of the right radial access approach is complex vessel anatomy, such as subclavian tortuosity. Several clinical predictors have been proposed for tortuosities, such as older age, female sex and hypertension. In this study, we hypothesised that chest radiography would add predictive value to the traditional predictors. Methods: This prospective blinded study included patients who underwent transradial access coronary angiography. They were classified into four groups according to difficulty: Group I, Group II, Group III and Group IV. Different groups were compared according to clinical and radiographic characteristics. Results: The study included 108 patients (54, 27, 17 and 10 patients in Groups I, II, III and IV, respectively). The rate of crossover to transfemoral access was 9.26%. Age, hypertension and female sex were associated with a greater difficulty and failure rates. Regarding radiographic parameters, a higher failure rate was associated with a higher diameter of the aortic knuckle (Group IV, 4.09 ± 1.32 cm versus Groups I, II and III combined, 3.26 ± 0.98 cm; p=0.015) and the width of the mediastinum (Group IV, 8.96 ± 2.88 cm versus Groups I, II and III combined, 7.28 ± 1.78 cm; p=0.009). The cut-off value for prominent aortic knuckle was 3.55 cm (sensitivity 70% and specificity 67.35%) and the width of mediastinum was 6.59 cm (sensitivity 90% and specificity 42.86%). Conclusion: Radiographic prominent aortic knuckle and wide mediastinum are valuable clinical parameters and useful predictors for transradial access failure caused by tortuosity of the right subclavian/brachiocephalic arteries or aorta.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e21"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9d/6c/icr-18-e21.PMC10331560.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9815518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective. 房颤患者经皮冠状动脉介入治疗后的抗血栓管理:欧洲视角。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2021.30

Antonio Greco, Claudio Laudani, Carla Rochira, Davide Capodanno

{"title":"Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective.","authors":"Antonio Greco, Claudio Laudani, Carla Rochira, Davide Capodanno","doi":"10.15420/icr.2021.30","DOIUrl":"https://doi.org/10.15420/icr.2021.30","url":null,"abstract":"AF is a highly prevalent disease, often requiring long-term oral anticoagulation to prevent stroke or systemic embolism. Coronary artery disease, which is common among AF patients, is often referred for myocardial revascularisation by percutaneous coronary intervention (PCI), which requires dual antiplatelet therapy to minimise the risk of stent-related complications. The overlap of AF and PCI is a clinical conundrum, especially in the early post-procedural period, when both long-term oral anticoagulation and dual antiplatelet therapy are theoretically indicated as a triple antithrombotic therapy. However, stacking drugs is not a desirable option because of the increased bleeding risk. Several strategies have been investigated to mitigate this concern, including shortening triple antithrombotic therapy duration and switching to a dual antithrombotic regimen. This review analyses the mechanisms underlying thrombotic complications in AF-PCI, summarises evidence surrounding antithrombotic therapy regimens and reports and comments on the latest European guidelines.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e05"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/14/d9/icr-18-e05.PMC10433110.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10424835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Transcatheter Mitral Valve Repair via MitraClip in Patients Aged <65 Years: Multicentre 2-year Outcomes. 年龄<65岁患者经导管二尖瓣MitraClip修复:多中心2年结果

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2021.28

Hassan Mh Mohammed, Ahmed Farah, Bjoern Plicht, Mohammad El-Garhy, Ilse Janicke, Amr Yousef, Mohammad Abdelkader AbdelWahab, Nasser M Taha, Wolfgang Schoels, Thomas Buck

{"title":"Transcatheter Mitral Valve Repair via MitraClip in Patients Aged <65 Years: Multicentre 2-year Outcomes.","authors":"Hassan Mh Mohammed, Ahmed Farah, Bjoern Plicht, Mohammad El-Garhy, Ilse Janicke, Amr Yousef, Mohammad Abdelkader AbdelWahab, Nasser M Taha, Wolfgang Schoels, Thomas Buck","doi":"10.15420/icr.2021.28","DOIUrl":"https://doi.org/10.15420/icr.2021.28","url":null,"abstract":"Background: Transcatheter mitral valve repair (TMVR) using the MitraClip has become a well-established interventional therapy and is usually performed in elderly patients. The objective of this study was to assess 2-year clinical outcomes of TMVR in patients aged <65 years at three heart centres with severe mitral regurgitation (MR) and no surgical options.Methods: A retrospective study analysed data of 36 patients aged <65 years treated with TMVR . All patients were refused surgery by Heart Team decision. Baseline MR was assessed by biplane vena contracta width in two perpendicular views (mean 8.35 ± 1.87 mm). Degenerative MR was detected in 11 patients (30.6%); functional MR was detected in 25 patients (69.4%).Results: Acute procedural success was accomplished in 88.9% of patients. No procedure-related mortality during the first 30 days was detected. Over an average of 2 years of follow-up, all-cause mortality was 19.4% and cardiovascular death was 11.1% owing to advanced heart failure. The average follow-up period was 25.8 months (median was 20 months). Statistically significant difference (p-value <0.01) was detected for N-terminal prohormone of brain natriuretic peptide (pg/ml) at baseline (mean 9,870 ± 10,819; median 7,748) compared to follow-up visits (mean 7,645 ± 11,292; median 3,263). New York Heart Association functional class improvement was achieved in 69% of patients. A second intervention (reclipping) was required in two patients to correct recurrent significant MR.Conclusion: TMVR in patients aged <65 years refused surgical repair provides satisfactory clinical outcomes at 2 years. Future studies should evaluate the outcomes of MitraClip in this population in a larger cohort.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e03"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/15/icr-18-e03.PMC10433109.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10040377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Coronary Artery Disease in Patients with Severe Mental Illness. 严重精神疾病患者的冠状动脉疾病。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.31

Brian Tam To, Roman Roy, Narbeh Melikian, Fiona P Gaughran, Kevin O'Gallagher

引用次数: 1

Combination of Laser Atherectomy and Super High-pressure Non-compliant Balloon to Treat Stent Under-expansion in Cases of Failed Interventional Options. 激光动脉粥样硬化切除术联合超高压非顺应球囊治疗介入失败的支架扩张不足。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.36

Viktor Sasi, Gyula Szántó, Alexandru Achim, Imre Ungi, Albert Varga, Zoltán Ruzsa

{"title":"Combination of Laser Atherectomy and Super High-pressure Non-compliant Balloon to Treat Stent Under-expansion in Cases of Failed Interventional Options.","authors":"Viktor Sasi, Gyula Szántó, Alexandru Achim, Imre Ungi, Albert Varga, Zoltán Ruzsa","doi":"10.15420/icr.2022.36","DOIUrl":"https://doi.org/10.15420/icr.2022.36","url":null,"abstract":"Patients with calcified, fibrotic native coronary vessels with prior suboptimal stenting outcomes are at major risk of stent thrombosis and could face serious consequences if untreated. In cases of multiple layers of under-expanded stents, the risk is multiplied. If conventional balloon post-dilatation is unsuccessful after stent implantation without proper lesion preparation, few interventional options remain. The authors report on a patient with prior numerous right coronary unsuccessful coronary interventions resulting in partially crushed multiple layers of stent material with critical lumen narrowing caused by stent under-expansion. Balloon angioplasty and stent rotational atherectomy (ROTA) had been attempted to overcome stent under-expansion but were unsuccessful. The authors investigated a new combination therapy of laser atherectomy (ELCA) and super high-pressure balloon (OPN non-compliant balloon) to treat single or multiple layers of stent with severe under-expansion due to fibrotic, calcified tissue surrounding the under-expanded stent structure.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e23"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/77/icr-18-e23.PMC10394584.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9935795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme. 阿拉伯联合酋长国经导管主动脉瓣置换术的结果:来自新兴项目的真实世界单中心经验。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.04

Ahmad Edris, Yosef Manla, Firas Al Badarin, Khwaja Hasan, Shahrukh Hashmani, Mahmoud Traina, Dhiaedin Khiati, Amani Khalouf, Anas El Zouhbi, Emin Murat Tuzcu

{"title":"Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme.","authors":"Ahmad Edris, Yosef Manla, Firas Al Badarin, Khwaja Hasan, Shahrukh Hashmani, Mahmoud Traina, Dhiaedin Khiati, Amani Khalouf, Anas El Zouhbi, Emin Murat Tuzcu","doi":"10.15420/icr.2022.04","DOIUrl":"https://doi.org/10.15420/icr.2022.04","url":null,"abstract":"Background: Data on outcomes of transcatheter aortic valve replacement (TAVR) in the Middle East, particularly in the United Arab Emirates (UAE), are limited. Whether centres with a low volume of patients requiring the procedure can achieve similar outcomes as those reported in pivotal clinical trials remains unclear. This study evaluates procedural outcomes of patients undergoing TAVR in a newly established programme in the UAE.Methods: Procedural outcomes of consecutive patients who underwent transfemoral TAVR at a single centre in the UAE between January 2016 and November 2021 were compared with those at centres in the lowest quartile (Q1) of procedural volume in the Transcatheter Valve Therapy Registry, which covers centres in the US.Results: Among the 183 patients included in the study, the median age was 76 years (interquartile range [IQR] 71-82), and 42.1% of patients were women, with a median Society of Thoracic Surgeons predicted risk of mortality score of 4.6 (IQR 2.9-7.5). Most of the patients (93.3%) received a balloon-expandable valve. All-cause death within 30 days, stroke and major vascular complications occurred in 0.6%, 0.6% and 2.2% of patients, respectively, compared with 3.1%, 2.2% and 4% in patients treated at Q1 hospitals.Conclusion: Patients undergoing transfemoral TAVR at an emerging centre in the Middle East had favourable outcomes compared with those performed at Q1 hospitals in the US. These findings suggest that careful patient selection for TAVR is critical and may help optimise patient outcomes, especially when procedural volumes are low.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e08"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/43/icr-18-e08.PMC10433106.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10052661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation? 房颤患者经皮冠状动脉介入治疗12个月后停止抗血小板治疗真的安全吗?

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.40

Balen Abdulrahman, Richard J Jabbour, Nick Curzen

{"title":"Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?","authors":"Balen Abdulrahman, Richard J Jabbour, Nick Curzen","doi":"10.15420/icr.2022.40","DOIUrl":"https://doi.org/10.15420/icr.2022.40","url":null,"abstract":"The prevalence of AF in patients with coronary artery disease is high. The guidelines from many professional groups, including the European Society of Cardiology, American College of Cardiology/American Heart Association and Heart Rhythm Society, recommend a maximum duration of 12 months of combination single antiplatelet and anticoagulation therapy in patients who undergo percutaneous coronary intervention and who have concurrent AF, followed by anticoagulation alone beyond 1 year. However, the evidence that anticoagulation alone without antiplatelet therapy adequately reduces the well-documented attritional risk of stent thrombosis after coronary stent implantation is relatively sparse, particularly given that very late stent thrombosis (>1 year from stent implantation) is the commonest type. By contrast, the elevated risk of bleeding from combined anticoagulation and antiplatelet therapy is clinically important. The aim of this review is to assess the evidence for long-term anticoagulation alone without antiplatelet therapy 1 year post-percutaneous coronary intervention in patients with AF.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e22"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/13/icr-18-e22.PMC10331563.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9812934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Percutaneous Transcatheter Closure of Post-infarction Ventricular Septal Defect: An Alternative to Surgical Intervention. 经皮经导管关闭梗死后室间隔缺损:手术干预的另一种选择。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2023.01

Diarmaid Cadogan, Marwa Daghem, Mostafa Snosi, Lynne K Williams, Jonathan Weir-McCall, Patrick A Calvert, Joel P Giblett

引用次数: 0

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension. 肾去神经:健康专业人员管理高血压的实用指南。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.38

Roland Schmieder, Michel Burnier, Cara East, Konstantinos Tsioufis, Sean Delaney

引用次数: 1

Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis. Myval:一种治疗严重主动脉瓣狭窄的新型经导管心脏瓣膜。

Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2020.32

Ashok Seth, Vijay Kumar, Vivudh Pratap Singh, Dhananjay Kumar, Puneet Varma, Vishal Rastogi

引用次数: 0